Analysts expect approval processes to continue over the coming years
2008;478:136e42
Because these conditions prevent adequate oral uptake, intramuscular injection bypasses the digestive system entirely and delivers B12 directly into muscle tissue for reliable absorption
Diarrhea is a side effect of how GLP-1 medications change digestion, not a measure of results
However, under electrophilic or oxidative stress, KEAP1 changes its structure and NRF2 dissociates from the complex, accumulates in the nucleus and induces the expression of its target genes involved in the antioxidant response, detoxification, metabolism and inflammation [11]
PROMISING POTENTIAL GLP-1RAs offer a promising outlook as transformative therapies in glycemic control, weight management, neuroprotection, and cardiovascular and renal protection